Evidence map›Paper›PMID 23277070›Full record

ReviewFrontiers in bioscience (Scholar edition)2013

The role of natural killer cells in pulmonary immunosurveillance.

Pamela Rose Hesker, Alexander Sasha Krupnick

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in bioscience (Scholar edition), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. IL-10-producing NK cells exacerbate sublethal Streptococcus pneumoniae infection in the lung.Translational research : the journal of laboratory and clinical medicine · 2020
    Article
  8. Article
  9. Article
  10. Integrative Physiology of Pneumonia.Physiological reviews · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. NK cells in mucosal defense against infection.BioMed research international · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pamela Rose HeskerDepartment of Surgery, Washington University School of Medicine, St Louis, MO, USA.
Alexander Sasha Krupnick
Washington University in St. Louis · US

Funding

The Role of Non-Hematopoietic Cells in Tumor Tolerance InductionK08CA131097 · NCI · WASHINGTON UNIVERSITY · PI KRUPNICK, ALEXANDER S. · 2008 to 2012
$710k
NCI NIH HHS K08 CA131097
6 · The paper itself

Abstract

Natural killer (NK) cells were originally identified as lymphocytes capable of killing cancer cells without prior sensitization (1). Further characterization of these cells in both humans and rodent models has expanded their role towards a broad-based immunosurveillance of diseased and healthy peripheral tissues. Among peripheral organs, the lung contains the largest percentage of NK cells. Accordingly, NK cells are implicated in many immunological responses within the lung, including innate effector functions as well as initiation of the adaptive immune response. In this article, we review the characteristics of NK cells, current models of NK maturation and cell activation, migration of NKs to the lung, and effector functions of NKs in cancer and infection in the airways. Specific emphasis is placed on the functional significance of NKs in cancer immunosurveillance. Therapeutic modulation of NK cells appears to be a challenging but promising approach to limit cancer, inflammation, and infection in the lung.

Indexed as

Adaptive ImmunityAnimalsHumansImmunologic SurveillanceInfectionsKiller Cells, NaturalLungLung NeoplasmsLymphocytesPneumoniaRespiratory Tract Infections

Identifiers

PMID23277070
PMCPMC4413461
OpenAlexW1972768630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.